Asia‐Pacific Survey on the Management of Helicobacter pylori Infection
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Koji Otani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents, Practice Patterns, Physicians'. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aim Gastric cancer (GC)‐related incidence and mortality rates remain high owing to Helicobacter pylori infection in Asia, and the importance of primary and secondary prevention of GC has been well recognized. We aimed to investigate the extent of overall agreement among clinicians in the Asia‐Pacific region regarding the management of H. pylori infection.
Methods
The Upper Gastrointestinal (GI) Focus Group of the Asian Pacific Association of Gastroenterology‐Emerging Leaders Committee developed an international survey, which was distributed to 98 clinicians in the Asia‐Pacific region, compromising an online questionnaire focusing on the management of H. pylori infection.
Results
Participants responded from Japan (15, 15.3%), Hong Kong (15, 15.3%), Thailand (33, 33.7%), Vietnam (23, 23.5%), Malaysia (4, 4.1%), Singapore (3, 3.1%), and others (5, 5.1%). The most common first‐line eradication regimen was clarithromycin (CAM) triple therapy, including proton pump inhibitor (PPI), amoxicillin (AMPC), and CAM (64.3%) for 14 days (70.4%). The most common second‐line eradication regimen was levofloxacin (LVX) triple therapy, including PPI, AMPC, and LVX (22.4%) for 14 days (67.3%). Eradication therapy was deemed necessary for all asymptomatic adults and minors (aged ≤ 17 years) currently infected with H. pylori by 81.6% and 64.3% of respondents, respectively, with 82.7% considering upper GI endoscopy for GC screening useful in the secondary prevention of GC.
Conclusion
There appears to be a growing consensus among clinicians, acknowledging the necessity of eradication therapy. We anticipate that this study will establish a new benchmark in preventive medicine aimed at eradicating GC in the Asia‐Pacific region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam.
- Internal Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand.
- Department of Medicine, Queen Elizabeth Hospital, Hong Kong.
- Gastroenterology and Hepatology Unit, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Richmond Gastroenterology Centre, Mount Elizabeth Medical Centre, Singapore.
ORCID-Profile: Koji Otani, Rapat Pittayanon, Kee Huat Chuah, Akira Higashimori
Zitieren
APA
Otani, K., Hang, D. V., Pittayanon, R., Liu, H., Chuah, K. H., Hsiang, J., Zhang, N., Higashimori, A., Fujiwara, Y., & Upper GI Focus Group of the APAGE‐ELC (2025). Asia‐Pacific Survey on the Management of Helicobacter pylori Infection. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16862
Vancouver
Otani K, Hang DV, Pittayanon R, Liu H, Chuah KH, Hsiang J, et al. Asia‐Pacific Survey on the Management of Helicobacter pylori Infection. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16862
BibTeX
@article{Otani2025,
author = {Otani, Koji and Hang, Dao Viet and Pittayanon, Rapat and Liu, Henry and Chuah, Kee Huat and Hsiang, John and Zhang, Ning and Higashimori, Akira and Fujiwara, Yasuhiro and Upper GI Focus Group of the APAGE‐ELC, Upper GI Focus Group of the APAGE‐ELC},
title = {Asia‐Pacific Survey on the Management of Helicobacter pylori Infection},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16862}
}
EUVIMED